← Back
$KLRS All transactions

Kalaris Therapeutics, Inc.

▼ SELL

$ Value

$13K

Shares

1,915

Price

$7

Filed

Mar 23

Insider

Name

Hagen Brett R

Title

Chief Accounting Officer

CIK

0001681782

Roles

Officer

Transaction Details

Transaction Date

2026-03-20

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Due to an administrative error, the Reporting Person filed a Form 4 on March 27, 2025 reporting beneficial ownership of 1,925 shares, when in fact the amount of securities beneficially owned was 1,915. The number of shares beneficially owned by the Reporting Person following the transaction reported herein has been updated accordingly. | The option was granted on March 19, 2026. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on March 19, 2027, and the remainder vesting in equal monthly installments thereafter, subject to continuous service.

Filing Info

Accession No.

0001193125-26-119707

Form Type

4

Issuer CIK

0001754068

Hagen Brett R's History

Date Ticker Type Value
2026-03-20 KLRS $13K
2026-03-19 KLRS A $0

Other Insiders at KLRS (90d)

Insider Bought Sold Last
AKKARAJU SRINIVAS $5.0M 2025-12-18
Hagen Brett R
Chief Accounting Officer
2026-03-19
Feinsod Matthew
Chief Medical Officer
2026-03-19
Oxtoby Andrew
See Remarks
2026-03-19
Gall Matthew
Chief Financial Officer
2026-03-19